Level Four Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,070
| Closed | -$668K | – | 835 |
|
|
2024
Q1 | $668K | Buy |
5,070
+128
| +3% | +$16.9K | 0.04% | 383 |
|
|
2023
Q4 | $651K | Buy |
+4,942
| New | +$651K | 0.04% | 388 |
|
|
2023
Q1 | – | Sell |
-5,772
| Closed | -$689K | – | 799 |
|
|
2022
Q4 | $689K | Sell |
5,772
-1,933
| -25% | -$231K | 0.05% | 327 |
|
|
2022
Q3 | $818K | Sell |
7,705
-4,761
| -38% | -$505K | 0.08% | 233 |
|
|
2022
Q2 | $1.22M | Buy |
12,466
+7,452
| +149% | +$726K | 0.11% | 188 |
|
|
2022
Q1 | $470K | Buy |
+5,014
| New | +$470K | 0.04% | 410 |
|